Tue, August 6, 2024

David Risinger Downgraded (TBPH) to Hold and Decreased Target to $10 on, Aug 6th, 2024

David Risinger of Leerink Partners, Downgraded "Theravance Biopharma, Inc." (TBPH) to Hold and Decreased Target from $15 to $10 on, Aug 6th, 2024.

David has made no other calls on TBPH in the last 4 months.



There is 1 other peer that has a rating on TBPH. Out of the 1 peers that are also analyzing TBPH, 0 agree with David's Rating of Hold.



This is the rating of the analyst that currently disagrees with David


  • Julian Harrison of "BTIG" Initiated at Strong Buy and Held Target at $21 on, Friday, April 12th, 2024